I have a BSc in Biomedical Science from the University of Surrey with a year in industry at AstraZeneca. After completing my MSc on ‘Genes, Drugs and Stem Cells- Novel Therapies’ at Imperial College London, I jointed the lab as part of the 4-year BHF-funded MRes+PhD scheme. My PhD investigates the role of endothelial heterogeneity with a focus on the process of endothelial-to-mesenchymal transition in the pathogenesis of tissue fibrosis.